Steven Bernstein
Analyst · the Securities and Exchange Commission. By making these forward-looking statements, the company undertakes no obligation to update these statements for revisions or changes after the date of this conference call. It is now my pleasure to introduce your host, Thomas McClelland, President and Chief Executive Officer
Thank you, Tom, and good afternoon. For the three-months ended July 31, 2023, consolidated revenue was $12.4 million compared to $8.2 million for the same period of the prior fiscal year. The components of revenue are as follows. Revenue from commercial and U.S. government satellite programs was approximately $5.1 million or 39% compared to $5.2 million or 51% in the same period of the prior fiscal year. Revenues on satellite payload contracts are recognized primarily under the percentage of completion method and are recorded only in the FEI-New York segment. Revenues from non-space U.S. government and DoD customers, which are recorded in both the FEI-New York and FEI-Zyfer segments were $6.9 million compared to $4.1 million in the same period of the prior fiscal year and accounted for approximately 55% of consolidated revenue compared to 50% for the prior fiscal year. Other commercial industrial revenues were approximately $672,000 compared to approximately $664,000 in the prior fiscal year. The increase in revenue for the three months ending July 31, '23 was mainly due to government non-space programs. For the three months ended July 31, '23, gross margin and gross margin rate increased compared to the same period in the prior fiscal year. The gross margin dollars increase is a direct result of the increase in revenue. The gross margin rate increased significantly due to two main factors. First, many of the technical challenges faced in early part of last fiscal year have been resolved. And as a result, the related programs are now moving forward. Second, during the three months ended July 31, '23, there were onetime contractual and other adjustments that also benefit the gross margin rate by approximately 8%. For the three months ending April -- July '23 and '22, SG&A expenses were approximately 19% and 24%, respectively of consolidated revenues. The consolidated decrease in SG&A expense of 5% for the three months ending July 31, '23 as compared to prior year period was largely due to the increase in revenue. R&D expense for the three months ending July 31, '23 decreased to approximately $506,000 from $1.1 million for the three months ending July 31, '22, a decrease of approximately $604,000 and were approximately 4% and 14%, respectively of consolidated revenue. R&D decrease for the three months ending July 31, '23 were due to dedicated R&D resources working on production orders to meet scheduled deadlines. The company plans to continue to invest in R&D in the future and keep its products at the state-of-the-art. For the three months ending July 31, '23, the company recorded operating income of approximately $2.1 million compared to an operating loss of approximately $3.1 million in the prior year. Operating income increased due to a combination of increase in revenue over the three months ended July 31, '22, increased gross margin and the effects of certain cost-cutting measures instituted by management beginning in fiscal year '23. Other income expense net is derived from various sources. The income can come from reclaiming of metal, refunds, interest on deferred trust assets or the sale of fixed assets. Interest expense is related to the deferred compensation payments made to retired employees. This yields pretax income of approximately $2 million for the three months ended July 31, '23 compared to an approximately $3.1 million pretax loss for the three months ended July 31, '22. For the three months ended July 31, '23, the company recorded a tax provision of $7,000 compared to a $1,000 provision for the same period in the prior fiscal year. Consolidated net income for the three months ending July 31, '23, was approximately $2 million or $0.22 per share compared to an approximate $3.1 million loss or negative $0.33 per share for the same period of the previous fiscal year. Our fully funded backlog at the end of July '23 was approximately $52 million compared to $56 million for the previous fiscal yearend, April 30, '23. In addition, this is the fourth consecutive quarter in which backlog is greater than $50 million level, a level the company has not seen in over 10 years. While some of this will turn into revenue and thus come out of backlog this year, we expect additional significant contract awards to be added to backlog in the coming quarters. The company's balance sheet continues to reflect a strong working capital position of approximately $23 million at July 31, '23 and a current ratio of approximately 1.9 to 1. Additionally, the company is debt free. The company believes that its liquidity is adequate to meet its operating and investing needs for the next 12 months and the foreseeable future. I will turn the call back to Tom and we look forward to your questions later.